Tag

Dr Smith is a Medical Director for Europe having joined Theradex® in February 2010.

He has background training in Medical Oncology with 15 years’ clinical practice experience. He is a graduate of the Royal College of Surgeons in Ireland and completed his postgraduate training in St Bartholomew and the Royal Marsden hospital. 

Dr Smith joined the industry with PPD as Lead Medical Director for Oncology (ex-US). His responsibilities at Theradex® include evaluation of the clinical, commercial feasibility and project strategy with clients; protocol development; and selecting and liaising with clinical investigators during the clinical trial progress. He is also responsible for assessing AE and SAEs for selected European studies, commenting and preparing narrative reports for onward reporting to clients, regulatory agencies, investigators and ethics committees as necessary.

Dr Smith is also responsible for medical review of data emerging from clients’ clinical trials and for advising clients on appropriate action to be taken based on the emerging data and to advise on risk management especially risk mitigation.

Dr Smith also has experience in early access patient schemes and advising on integrating market access programs in the product lifecycle development.

Dr Smith is a member of both American Society of Clinical Oncologists and European Society of Medical Oncology.